[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fdr5iaON5n7lLmIxm3R6nOGPnve_vmzniE62NSreDzX0":8,"$fN1ihjOGJ2168IoKQKhr1zJlkAxrCqHLOTMFcu_mUs1w":55,"$fxQV1LWyE4qWs5FkIChQDZNCR7J2l0R8ea97cO-zg4Dk":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},50722,867193,[],"https://ystcdn.venuertc.com/medical/ystApp/RrM5xDxVhrr4fpz5auCKTz2MWSI8FfTX.png","马晓阳","安丘市人民医院","普外科","住院医师",311,0,"乳腺癌早期靶向治疗用药：安全实用全攻略","","https://ystcdn.venuertc.com/venue/AI/8d7c43f6-8022-4a29-8abb-8f03edb18c93.jpg","\u003Cdiv class=\"breast-drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"breast-drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌早期靶向治疗用药：安全实用全攻略\u003C/h2>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#fafcff 10%,#f7f0f9 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">开篇导语 🧬 从用药细节谈起\u003C/h2>\n    \u003Cp class=\"breast-drug-guide-p\">\n      说起乳腺癌的靶向药物，用得较多的有曲妥珠单抗和帕妥珠单抗。这类药物属于单克隆抗体，广泛用于不少患者的治疗过程中。虽然不少人都听过它们的大名，但具体用法、安全禁忌和和生活中的注意事项，可能没能说得很全。本文将系统解读7个核心用药细节，帮大家清楚记住，如何安全、有效地使用这些靶向药物。  \n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#f7f8fa 10%,#eef5fd 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 🎯 靶向药物的成分、剂型与作用机制\u003C/h2>\n    \u003Cp class=\"breast-drug-guide-p\">\n      市面上用于乳腺癌早期靶向治疗的主流药物有\u003Cb>曲妥珠单抗（Trastuzumab）\u003C/b>和\u003Cb>帕妥珠单抗（Pertuzumab）\u003C/b>。这两种药物均属于单克隆抗体，用于联合或单独注射。\u003Cbr>\n      \u003Cb>曲妥珠单抗\u003C/b>：活性成分为人源化抗HER2抗体，采用粉针或注射液形式，常见规格有150mg/瓶和420mg/瓶。\u003Cbr>\n      \u003Cb>帕妥珠单抗\u003C/b>：也是单克隆抗体，规格多为420mg/瓶注射剂。\u003Cbr>\n      这类药物直接作用于HER2受体，阻断信号通路，调控细胞生长。简单说，就是“定向干扰”异常蛋白的功能，让药物把作用力集中在靶点上，减少对健康细胞的伤害（Swain, S. M., et al., 2015）。\n    \u003C/p>\n  \u003C/div> \n \n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#f5fafe 0%,#f8f3f8 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 ⏰ 给药时间与使用方法\u003C/h2>\n    \u003Cp class=\"breast-drug-guide-p\">\n      靶向治疗药物\u003Cb>必须\u003C/b>通过静脉滴注完成，不能口服，也不建议自行注射。每种药物首剂和维持剂量、给药时间都有明确要求：\u003Cbr>\n      \u003Cspan class=\"breast-drug-guide-chip\">曲妥珠单抗\u003C/span>：首次滴注通常用量为8mg/kg体重，之后每3周6mg/kg；每次滴注时间≥90分钟，若耐受可缩短至30分钟。\u003Cbr> \n      \u003Cspan class=\"breast-drug-guide-chip\">帕妥珠单抗\u003C/span>：首剂840mg，之后每3周420mg，给药时间类似。两个药物可以联合、也可以单用，具体方案医生定。\u003Cbr>\n      \u003Cb>用药期间要点\u003C/b>：\u003Cbr>\n      \u003C/p>\u003Cul class=\"breast-drug-guide-list\">\n        \u003Cli>滴注过程中需持续观察，不能擅自离开，防意外反应。\u003C/li>\n        \u003Cli>若出现任何不适应立刻通知医护人员。\u003C/li>\n      \u003C/ul>\n      \u003Cb>正确做法\u003C/b>：“按时按量，现场有医护观察”是保障治疗效果和用药安全的关键。\n    \u003Cp>\u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#fbf8fe 0%,#f4f8fc 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 💧 剂型细节与应用技巧\u003C/h2>\n    \u003Cp class=\"breast-drug-guide-p\">\n      单克隆抗体药物主要是粉针剂或现成注射液。\u003Cbr>\n      \u003C/p>\u003Cul class=\"breast-drug-guide-list\">\n        \u003Cli>粉针需用专用溶剂（通常为注射用水或生理盐水）调配，\u003Cb>由专业人员操作\u003C/b>，自行调配不可取。\u003C/li>\n        \u003Cli>溶解后应尽快用完，现场配制现场使用，减少污染风险。\u003C/li>\n      \u003C/ul>\n      药物需通过滴注泵均匀注入体内。\u003Cbr>\n      \u003Cb>小妙招\u003C/b>：用药当天宜清淡饮食，避免油腻和刺激性食物。有的人会问要不要喝很多水？其实可根据个人状况适量饮水，但不需特意大量补水。\n    \u003Cp>\u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#f6fafc 0%,#fbeff7 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 ⚠️ 相互作用及特殊禁忌——绝不能忽视\u003C/h2>\n    \u003Cp class=\"breast-drug-guide-p\">\n      \u003Cb>化疗药物联合\u003C/b>：\u003Cbr>\n      曲妥珠单抗和帕妥珠单抗经常与化疗药物（如紫杉醇）共同应用，\u003Cb>但须遵守医嘱\u003C/b>，严格观察有无叠加毒性。\u003Cbr>\n      \u003Cb>不能与哪些药同用？\u003C/b>\u003Cbr>\n      \u003C/p>\u003Cul class=\"breast-drug-guide-list\">\n        \u003Cli>拟同步使用蒽环类药物（如多柔比星）时，需评估心脏毒性累加风险。\u003C/li>\n        \u003Cli>与强心苷等增加心脏负担的药物一同使用要特别小心。\u003C/li>\n        \u003Cli>同时使用皮质类固醇、免疫抑制剂，可能会调节药效，应事先咨询医生。\u003C/li>\n      \u003C/ul>\n      \u003Cb>特殊禁忌：\u003C/b>\n      \u003Cul class=\"breast-drug-guide-list\">\n        \u003Cli>严重心衰、重度过敏史、静脉滴注过程中曾有严重反应者严禁再次使用。\u003C/li>\n        \u003Cli>对蛋白类药物高度过敏者禁用。\u003C/li>\n      \u003C/ul>\n    \u003Cp>\u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#fef6fa 0%,#f5fcfa 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 👩‍⚕️ 特殊人群用药，别忽视这些调整\u003C/h2>\n    \u003Cp class=\"breast-drug-guide-p\">\n      \u003C/p>\u003Cul class=\"breast-drug-guide-list\">\n        \u003Cli>\u003Cb>老年患者\u003C/b>：如合并心脏疾病，需评估心脏功能，必要时调整剂量或给药间隔。\u003C/li>\n        \u003Cli>\u003Cb>肝/肾功能异常\u003C/b>：轻中度损伤一般无需显著调整，但重度损伤不用建议，具体由医生综合判断。\u003C/li>\n        \u003Cli>\u003Cb>孕妇及哺乳期女性\u003C/b>：用药前\u003Cb>必须\u003C/b>权衡利弊。动物实验和临床数据均提示有胎儿风险，处于妊娠期、准备怀孕或正在哺乳时须主动告知医师。\u003C/li>\n        \u003Cli>\u003Cb>儿童\u003C/b>：一般不推荐使用。\u003C/li>\n      \u003C/ul>\n    \u003Cp>\u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#f6fcf7 0%,#fcf3f9 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 🩺 常见不良反应与处理办法\u003C/h2>\n    \u003Cp class=\"breast-drug-guide-p\">\n      \u003Cspan class=\"breast-drug-guide-chip\">心脏毒性\u003C/span>：曲妥珠单抗、帕妥珠单抗两者都可影响心脏收缩功能。数据显示，联合用药心脏不良反应发生率在11%-18%（Swain, S. M., et al., 2013）。需监测心超。\u003Cbr>\n      \u003Cspan class=\"breast-drug-guide-chip\">输液反应\u003C/span>：首次滴注时，临床上10-15%患者会有发热、寒战、头晕等情况。一般通过减慢滴速或对症处理缓解。\u003Cbr>\n      \u003Cspan class=\"breast-drug-guide-chip\">骨髓抑制\u003C/span>：特别是与化疗药联合时有骨髓抑制案例，应持续监测血常规。\u003Cbr>\n      \u003Cspan class=\"breast-drug-guide-chip\">其他\u003C/span>：皮疹、腹泻、肝功能指标波动等也可见。如持续加重需及时联系医生。\u003Cbr>\n      \u003Cb>正确做法\u003C/b>：用药期间主动报告每一次异常感觉，为后续治疗做出调整。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#f5f9fd 0%,#fdf7fa 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 🧊 储存方法和有效期管理\u003C/h2>\n    \u003Cp class=\"breast-drug-guide-p\">\n      \u003Cb>曲妥珠单抗\u003C/b>、\u003Cb>帕妥珠单抗\u003C/b>原装药品\u003Cb>必须\u003C/b>：\n      \u003C/p>\u003Cul class=\"breast-drug-guide-list\">\n        \u003Cli>于2-8℃冷藏保存，不可冷冻。\u003C/li>\n        \u003Cli>避免阳光直晒，储存在原包装内。\u003C/li>\n        \u003Cli>开瓶后应立即使用，未用完部分不得重复使用。\u003C/li>\n        \u003Cli>过期药品需依规定处置，勿自行丢弃。\u003C/li>\n      \u003C/ul>\n    \u003Cp>\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#fafcff 0%,#eceffb 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 💡 案例学用法：药物经验小结\u003C/h2>\n    \u003Cdiv class=\"breast-drug-guide-case\">\n      \u003Cp>\n        \u003Cb>案例1：\u003C/b>一位成年女性接受曲妥珠单抗＋帕妥珠单抗联合化疗时，因出现骨髓抑制被及时调整化疗强度，继续维持靶向治疗，获得良好耐受。\n      \u003C/p>\n      \u003Cp>\n        \u003Cb>案例2：\u003C/b>有患者因滴注过程中出现输液反应，经减慢速度并对症给药，未影响疗程进度。 \n      \u003C/p>\n      \u003Cp>\n        \u003Cb>案例3：\u003C/b>部分老年患者在用药期间加强心脏功能监测，发现异常指标后调整药物方案，避免了严重不良反应。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#f7f0f9 0%,#f3faf6 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 📝 细节问答 & 常见误区解析\u003C/h2>\n    \u003Cul class=\"breast-drug-guide-list\">\n      \u003Cli>\u003Cb>Q：\u003C/b>药物联合一定更好吗？\u003Cbr>\n          \u003Cb>正确做法：\u003C/b>合理联合利于提高疗效，但会增加不良反应风险，必须由专业医生评估后才决定用药方案。\n      \u003C/li>\n      \u003Cli>\u003Cb>Q：\u003C/b>漏用一次怎么办？\u003Cbr>\n          \u003Cb>正确做法：\u003C/b>发现后第一时间联系医疗团队，切勿自作主张自行补打。\n      \u003C/li>\n      \u003Cli>\u003Cb>Q：\u003C/b>服用化疗药时能否自行使用止吐药？\u003Cbr>\n         \u003Cb>正确做法：\u003C/b>部分止吐药可能与靶向药物有交互作用，建议提前和医生沟通。\n      \u003C/li>\n      \u003Cli>\u003Cb>Q：\u003C/b>家庭储存药品能冷冻吗？\u003Cbr>\n          \u003Cb>正确做法：\u003C/b>此类药品严禁冷冻，只能冷藏且保存环境要稳定。\n      \u003C/li>\n      \u003Cli>\u003Cb>Q：\u003C/b>未用完的溶液能否下次复用？\u003Cbr>\n        \u003Cb>正确做法：\u003C/b>所有开瓶后药物\u003Cb>当日用尽\u003C/b>，剩余必须弃用，避免二次污染与疗效下降。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#fbf8fe 0%,#effafd 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 ✨ 总结：安全用药，从细节做起\u003C/h2>\n    \u003Cp class=\"breast-drug-guide-p\">\n      乳腺癌早期靶向治疗用药，细节决定成败。\u003Cb>静脉滴注、专人操作、规范冷藏、及时报告不良反应\u003C/b>，是全程的“安全线”。遇到用药疑问，不要自行调整或中断药物。每一位用户都应成为自己健康的把关人，配合专业医疗管理，最大化提升药物的疗效与安全。\n    \u003C/p>\n    \u003Cp class=\"breast-drug-guide-p\">\n      \u003Cb>特别提醒\u003C/b>：每位患者具体用药应个体化，本文解读仅用于药品知识学习，如需调整，请与专业医师充分沟通。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"breast-drug-guide-section\" style=\"background:linear-gradient(90deg,#f5fafe 0%,#f8f3f8 100%);\">\n    \u003Ch2 class=\"breast-drug-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔗 主要参考文献\u003C/h2>\n    \u003Cul class=\"breast-drug-guide-biblist\">\n      \u003Cli>\n        Swain, S. M., Baselga, J., Kim, S. B., et al. (2015). Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 372(8), 724–734. DOI:10.1056/NEJMoa1413513\n      \u003C/li>\n      \u003Cli>\n        Swain, S. M., Ewer, M. S., Viale, G., et al. (2013). Cardiovascular Toxicity Associated with Trastuzumab in the Setting of Adjuvant Therapy: A Review of the Literature. \u003Ci>The Oncologist\u003C/i>, 18(3), 295–307.\n      \u003C/li>\n      \u003Cli>\n        Smith, I., Procter, M., Gelber, R. D., et al. (2007). 2-Year Follow-Up of Trastuzumab after Adjuvant Chemotherapy in HER-2–Positive Breast Cancer: A Randomized Controlled Trial. \u003Ci>Lancet\u003C/i>, 369(9555), 29–36.\n      \u003C/li>\n      \u003Cli>\n        National Comprehensive Cancer Network. (2022). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 4.2022.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.breast-drug-guide-container {\n  background:#fff;\n  padding:36px 10% 32px 10%;\n  font-family:'Segoe UI',Arial,'Microsoft YaHei',sans-serif;\n  font-size:18px;\n  line-height:1.8;\n  color:#2c2c2c;\n  box-sizing:border-box;\n  max-width:980px;\n  margin:32px auto;\n  border-radius:12px;\n  box-shadow:0 2px 24px 0 rgba(70,117,203,.07);\n}\n\n.breast-drug-guide-title {\n  font-size:2.2rem;\n  padding-bottom:16px;\n  border-bottom:2px solid #f4e5f5;\n  background:linear-gradient(90deg,#edf1fa 10%,#fae2fe 100%);\n  border-radius:10px 10px 0 0;\n  font-weight:700;\n  text-align:left;\n  margin-bottom:38px;\n  letter-spacing:2px;\n  color:#6e3fa8;\n}\n\n.breast-drug-guide-section {\n  margin-bottom:32px;\n  padding:30px 32px 24px 32px;\n  border-radius:12px;\n  box-shadow:0 0 13px 0 rgba(220,200,230,0.09);\n  position:relative;\n  overflow:hidden;\n}\n\n.breast-drug-guide-h2 {\n  font-size:1.28em;\n  font-weight:600;\n  margin-bottom:19px;\n  letter-spacing:1.2px;\n  color:#574c77;\n  background:rgba(255,255,255,.40);\n  padding:6px 18px 6px 8px;\n  border-radius:7px;\n  display:inline-block;\n  vertical-align:middle;\n}\n\n.breast-drug-guide-p{\n  margin:11px 0 9px 0;\n  font-size:1.07em;\n  color:#2a2636;\n}\n.breast-drug-guide-list{\n  margin:6px 0 6px 22px;\n  padding-left:5px;\n  font-size:1em;\n}\n.breast-drug-guide-list li{\n  margin-bottom:9px;\n  color:#34455a;\n  list-style:disc;\n}\n.breast-drug-guide-chip{\n  display:inline-block;\n  background:#ede7f7;\n  color:#824db1;\n  font-weight:500;\n  border-radius:7px;\n  padding:2px 11px;\n  margin-right:6px;\n  font-size:1.01em;\n  vertical-align:middle;\n}\n.breast-drug-guide-case{\n  background:#f8f8fb;\n  border-left:5px solid #dfc7eb;\n  padding:14px 18px;\n  border-radius:8px;\n  margin:2px 0 10px 0;\n  color:#50316a;\n  font-style:italic;\n}\n\n.breast-drug-guide-biblist{\n  margin:9px 0 5px 26px;\n  padding-left:2px;\n  color:#425b7b;\n  font-size:0.98em;\n}\n.breast-drug-guide-biblist li{\n  margin-bottom:8px;\n  line-height:1.7;\n}\n\n/* 响应式对移动端适配 */\n@media (max-width:700px){\n  .breast-drug-guide-container{\n    padding:12px 5% 16px 5%;\n  }\n  .breast-drug-guide-title{\n    font-size:1.21rem;\n    padding-bottom:10px;\n  }\n  .breast-drug-guide-section{\n    padding:16px 7px 14px 12px;\n    font-size:15px;\n  }\n  .breast-drug-guide-h2{\n    font-size:1.09em;\n    padding:5px 7px 5px 5px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"breast-drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"breast-drug-guide-title\" ",519,"2025-07-21 11:53:39","乳腺癌, 靶向治疗, 曲妥珠单抗, 帕妥珠单抗, 用药注意","本文详细介绍乳腺癌早期靶向治疗药物的成分、用法和注意事项，确保广大患者安全、有效地使用曲妥珠单抗和帕妥珠单抗，提升生活质量。","2025-07-29 16:18:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]